PYPD
Price
$3.33
Change
-$0.03 (-0.89%)
Updated
Sep 26 closing price
Capitalization
53.02M
39 days until earnings call
SER
Price
$4.97
Change
-$0.01 (-0.20%)
Updated
Sep 26 closing price
Capitalization
50.95M
Interact to see
Advertisement

PYPD vs SER

Header iconPYPD vs SER Comparison
Open Charts PYPD vs SERBanner chart's image
PolyPid
Price$3.33
Change-$0.03 (-0.89%)
Volume$73.64K
Capitalization53.02M
Serina Therapeutics
Price$4.97
Change-$0.01 (-0.20%)
Volume$10.3K
Capitalization50.95M
PYPD vs SER Comparison Chart in %
Loading...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PYPD vs. SER commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PYPD is a Buy and SER is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (PYPD: $3.34 vs. SER: $4.97)
Brand notoriety: PYPD and SER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PYPD: 121% vs. SER: 7%
Market capitalization -- PYPD: $53.02M vs. SER: $50.95M
PYPD [@Biotechnology] is valued at $53.02M. SER’s [@Biotechnology] market capitalization is $50.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PYPD’s FA Score shows that 1 FA rating(s) are green whileSER’s FA Score has 0 green FA rating(s).

  • PYPD’s FA Score: 1 green, 4 red.
  • SER’s FA Score: 0 green, 5 red.
According to our system of comparison, PYPD is a better buy in the long-term than SER.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PYPD’s TA Score shows that 2 TA indicator(s) are bullish while SER’s TA Score has 5 bullish TA indicator(s).

  • PYPD’s TA Score: 2 bullish, 5 bearish.
  • SER’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SER is a better buy in the short-term than PYPD.

Price Growth

PYPD (@Biotechnology) experienced а -3.33% price change this week, while SER (@Biotechnology) price change was -1.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

PYPD is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYPD($53M) and SER($50.9M) have the same market capitalization . PYPD YTD gains are higher at: 9.704 vs. SER (-0.798). SER has higher annual earnings (EBITDA): -12.47M vs. PYPD (-33.1M). PYPD has more cash in the bank: 29.5M vs. SER (6.04M). SER has less debt than PYPD: SER (185K) vs PYPD (8.67M). PYPD (0) and SER (0) have equivalent revenues.
PYPDSERPYPD / SER
Capitalization53M50.9M104%
EBITDA-33.1M-12.47M266%
Gain YTD9.704-0.798-1,215%
P/E RatioN/A1.51-
Revenue00-
Total Cash29.5M6.04M488%
Total Debt8.67M185K4,686%
FUNDAMENTALS RATINGS
SER: Fundamental Ratings
SER
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PYPDSER
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 19 days ago
75%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JAPSY10.380.10
+0.97%
Japan Airlines Ltd
FKWL4.200.02
+0.48%
Franklin Wireless Corp
ITCFY17.00N/A
N/A
Investec Ltd.
WONDF0.24N/A
-1.36%
Wonderfi Technologies Inc.
DSHK0.09N/A
-3.16%
Drive Shack Inc.

PYPD and

Correlation & Price change

A.I.dvisor tells us that PYPD and SLGL have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and SLGL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
-1.04%
SLGL - PYPD
26%
Poorly correlated
+3.57%
SER - PYPD
26%
Poorly correlated
-0.20%
PRTA - PYPD
25%
Poorly correlated
+0.53%
NUVL - PYPD
25%
Poorly correlated
+4.99%
CING - PYPD
24%
Poorly correlated
+0.53%
More

SER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SER has been loosely correlated with GERN. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SER jumps, then GERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SER
1D Price
Change %
SER100%
-0.20%
GERN - SER
65%
Loosely correlated
+1.57%
XTLB - SER
59%
Loosely correlated
-1.68%
ELVN - SER
37%
Loosely correlated
+7.75%
ENTBF - SER
35%
Loosely correlated
-9.76%
TOVX - SER
34%
Loosely correlated
+1.90%
More